Advanced Healthcare Materials · 2024 · 15 citations · 37 references
Life SciencesOncologyPharmacologyDrug DeliveryImmunotherapyNanoparticle Drug DeliveryCancer NanomedicineInflammatory SignalingNanocarriers For TherapeuticsNanomedicinePhotodynamic TherapyPhotothermal TherapyAntitumor Immune ActivationImmunogenic Cell Death InductionMolecular TargetingPhotodynamic Therapy-induced Immunogenic Cell DeathPhotothermal EffectsProgrammed Death-ligand 1 InhibitionProgrammed Death-ligand 1 InhibitorsTumor-targeted Drug Delivery
Abstract Phototherapy promotes anti‐tumor immunity by inducing immunogenic cell death (ICD), However, the accompanying inflammatory responses also trigger immunosuppression, attenuating the efficacy of photo‐immunotherapy. Herein, they co‐assembled a cell‐membrane targeting chimeric peptide C16‐Cypate‐RRKK‐PEG 8 ‐COOH (CCP) and anti‐inflammatory diclofenac (DA) to develop a nanodrug (CCP@DA) that both enhances the immune effect of phototherapy and weakens the inflammation‐mediated immunosuppression. CCP@DA achieves cell membrane‐targeting photodynamic and photothermal synergistic therapies to damage programmed death ligand 1 (PD‐L1) and induce a strong ICD to activate anti‐tumor response. Simultaneously, the released DA inhibits the cycoperoxidase‐2 (COX‐2)/prostaglandin E2 (PGE 2 ) pathway in tumor cells to inhibit pro‐tumor inflammation and further down‐regulate PD‐L1 expression to relieve the immunosuppressive microenvironment. CCP@DA significantly inhibited tumor growth and inflammation both in vitro and in vivo, while maintaining a potent anti‐tumor immune response. Additionally, it exhibits excellent anti‐metastatic capabilities and prolongs mouse survival time with a single dose and low levels of near‐infrared (NIR) light exposure. This work provides a valuable strategy to control the therapy‐induced inflammation for high‐efficiency photoimmunotherapy.
37
Jan P. Böttcher, Eduardo Bonavita, Probir Chakravarty et al. · Cell · 2018 · 1.8K citations · Full text
Medicine, Immunology, Oncology +17
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay, Annemarthe G. van der Veen, Jan P. Böttcher et al. · Cell · 2015 · 1.1K citations · Full text
Medicine, Immunology, Oncology +17
Victor Prima, Lyudmila N. Kaliberova, Sergey A. Kaliberov et al. · Proceedings of the National Academy of Sciences · 2017 · 491 citations · Full text
Life Sciences, Immunology, Oncology +17